Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.1.14 (
SPS
)
813
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Reactions of Ln(
BH4
)3(THF)n and [Li(Et2O)]
SPS
(Me)], the lithium salt of an anionic
SPS
pincer ligand composed of a central hypervalent lambda4-phosphinine ring bearing two ortho-positioned diphenylphosphine sulfide sidearms, led to the monosubstituted compounds [Ln(
BH4
)2(
SPS
(Me))(THF)2] [Ln = Ce (1), Nd (2)], while the homoleptic complexes [Ln(
SPS
(Me))3] [Ln = Ce (3), Nd (4)] were obtained by treatment of LnX3 (X = I,
BH4
) with [K(Et2O)][
SPS
(Me)]. The [UX2(
SPS
(Me))2] complexes [X = Cl (5),
BH4
(6)] were isolated from reactions of UX4 and the lithium or potassium salt of the [
SPS
(Me)]- anion. The X-ray crystal structures of 1.1.5THF, 2.1.5THF, 3.2THF.2Et2O, and 5.4py reveal that the flexible tridentate [
SPS
(Me)]- anion is bound to the metal as a tertiary phosphine with electronic delocalization within the unsaturated parts of the ligand.
...
PMID:Lanthanide and uranium complexes with an SPS-based pincer ligand. 1711 89
